EarlySense secures $39M for patient monitoring solutions
The majority of the funding came from hospital bed manufacturer Hill-Rom and Wells Fargo Strategic Capital, the venture capital and growth equity investment arm of Wells Fargo & Company.
The majority of the funding came from hospital bed manufacturer Hill-Rom and Wells Fargo Strategic Capital, the venture capital and growth equity investment arm of Wells Fargo & Company.
A new Frost and Sullivan report suggests that post-acute care facilities could strengthen their positions in an increasingly competitive landscape by integrating continuous monitoring technology and improving the outcome of high acuity patients.
Closing cancer health equity gaps require medical breakthroughs made possible by new funding approaches.
EarlySense CEO Avner Halperin said the funding will be used to accelerate our commercial growth in the hospital/ nursing home market.
Medical device maker EarlySense has received a green light for an updated version of its FDA-approved patient monitoring device. The tool uses a pad-sized sensor that fits under the mattress to transmit data on respiration and heart rate as well as movement to a bedside monitor and a monitor at a nurse station. The updated […]
EarlySense Ltd. announced its intentions to open its U.S. headquarters in Massachusetts. The move is a “direct result” of Mass. Gov. Deval Patrick’s March trip to Israel, where he met with EarlySense officials, according to a Mass. Life Sciences Center official. “He convinced us that Massachusetts would be the best location to run our national […]
EarlySense has raised $7 million in investment funding to continue commercializing its patient monitoring system for hospitals, bringing its fundraising for the year to an impressive $20 million.
Israeli medical device company EarlySense Ltd. announced today that its EverOn Central Display Station -- which accompanies its EverOn Touch patient monitoring system -- has been cleared for marketing in the United States by the Food and Drug Administration.
Updated 12:20 p.m., June 22, 2010. Israeli medical device company EarlySense Ltd., which recently closed a $13 million fundraising round, has received Food and Drug Administration (FDA) clearance to sell its EverOn Touch patient-monitoring system in the United States. The company based in Ramat Gan, Israel, also is pursuing European market clearance for the enhanced […]
Updated 6:59 p.m. Israeli device company EarlySense has raised $13 million from investors to launch its EverOn patient monitoring system in the United States and Europe. The company based in Ramat Gan, Israel last year received a grant from the Global Cardiovascular Innovation Center led by the Cleveland Clinic. At that time, EarlySense said it […]
EarlySense, which monitors a series of vital signs in hospitals and home health care settings, is among four companies that will share $2 million in grants from the Global Cardiovascular Innovation Center (GCIC).
Greater Cleveland likes promising Israeli medical companies. The next best opportunity for Cleveland to grab an Israeli company is probably EarlySense, which has created a monitoring system for hospitals and home health care settings. All it may take are investors and customers.